Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The application of MSC-derived secretome has been studied towards different pathologies by counteracting inflammation while inducing tissue regeneration namely in lung, hepatic and brain tissues.”
From Mesenchymal stem cell secretome for regenerative medicine: Where do we stand? (2025) · cites this paper as [160]
In the citing paper
“Nevertheless, this cell-free approach has also been reported with beneficial effects for other pathologies, including bone tissue, cardiovascular, intestinal and renal diseases [158], [159], [160], [161], [162], [163], [164], [165], [166], [167], [168], [169], [170] (Table 2).”
From Mesenchymal stem cell secretome for regenerative medicine: Where do we stand? (2025) · cites this paper as [160]
Citations
Cites
Bone marrow cells regenerate infarcted myocardium
Orlic, D., Kajstura, J., Chimenti, S., Jakoniuk, I., Anderson, S. M., Li, B., Pickel, J., McKay, R., Nadal-Ginard, B., Bodine, D. M., et al. (2001) · Nature · doi:10.1038/35070587 · Cited by 5,155
Human Mesenchymal Stem Cells Differentiate to a Cardiomyocyte Phenotype in the Adult Murine Heart
Toma, C., Pittenger, M. F., Cahill, K. S., Byrne, B. J., & Kessler, P. D. (2002) · Circulation · doi:10.1161/hc0102.101442 · Cited by 2,234
Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells
Jackson, K. A., Majka, S. M., Wang, H., Pocius, J., Hartley, C. J., Majesky, M. W., Entman, M. L., Michael, L. H., Hirschi, K. K., & Goodell, M. A. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12150 · Cited by 1,960
Mangi, A. A., Noiseux, N., Kong, D., He, H., Rezvani, M., Ingwall, J. S., & Dzau, V. J. (2003) · Nature Medicine · doi:10.1038/nm912 · Cited by 1,509
Self-citationKajstura, J., Cheng, W. N., Krzysztof Reiss, F., CLARK, W. A., Sonnenblick, E. H., Krajewski, S., Reed, J., Olivetti, G., & Anversa, P. (1996) · PubMed · Cited by 1,039
Nygren, J. M., Jovinge, S., Breitbach, M., Säwén, P., Röll, W., Hescheler, J., Taneera, J., Fleischmann, B. K., & Jacobsen, S. E. W. (2004) · Nature Medicine · doi:10.1038/nm1040 · Cited by 1,037
Friedrich, J. O., Apstein, C. S., & Ingwall, J. S. (1995) · Circulation · doi:10.1161/01.cir.92.12.3527 · Cited by 43
Self-citation
Research works printed but not linked: 3
- Tomita, S. et al. Circulation 100 (19 Suppl), II247–56 (1999).
- Gnecchi, M. et al. Circulation 110 (17 Suppl), III249 (2004).
- Kajstura, J. et al. Lab. Invest. 74, 86–107 (1996).
Cited by
Items 701–800 of 1,000
Guo, H.-D., Cui, G.-H., Tian, J.-X., Lu, P., Zhu, Q., Lv, R., & Shao, S.-J. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.08.104 · Cited by 37
“It has been reported that MSCs produce various kinds of cytokines that can exert beneficial effects on surrounding cells [4].”
BackgroundRogers, T. B., Pati, S., Gaa, S. A., Riley, D. D., Khakoo, A. Y., Patel, S. S., Wardlow, R. D., Frederick, C. A., Hall, G., He, L.-P., et al. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.09.001 · Cited by 38
Korkmaz‐Icöz, S., Li, S., Hüttner, R., Ruppert, M., Radovits, T., Loganathan, S., Sayour, A. A., Brlecic, P., Lasitschka, F., Karck, M., et al. (2018) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2018.12.003 · Cited by 38
Purity Determines the Effect of Extracellular Vesicles Derived from Mesenchymal Stromal Cells
Forteza‐Genestra, M. A., Antich-Rosselló, M., Calvo, J., Gayà, A., Monjo, M., & Ramis, J. M. (2020) · Cells · doi:10.3390/cells9020422 · Cited by 41
Cardiac Progenitor Cell Commitment Is Inhibited by Nuclear Akt Expression
Fischer, K. M., Din, S., Gude, N. A., Konstandin, M. H., Wu, W., Quijada, P. J., & Sussman, M. A. (2011) · Circulation Research · doi:10.1161/circresaha.110.237156 · Cited by 39
Wei, H., Wong, P., Hsu, L., & SHIM, W. S. N. (2009) · PubMed · Cited by 44
Yang, J., Yang, X., Liu, Z., Hu, S., Du, Z., Feng, L., Liu, J., & Chen, Y. (2012) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.226.231 · Cited by 36
“Via transduction with certain protective cytokines or variants, such as VEGF (Tang et al. 2010), IGF (Haider et al. 2008) and AKT (Gnecchi et al. 2005), among others.”
BackgroundDeveza, L. R., Choi, J. H.-K., Imanbayev, G., & Yang, F. (2012) · Stem Cells and Development · doi:10.1089/scd.2012.0201 · Cited by 37
“In support of this view, it was shown that direct injection of conditioned medium (CM) from BMMSC versus BMMSC transplantation into a rat model of myocardial ischemia led to similar reductions in infarct size and improvements in ventricular function by 72 h [12].”
Yokokawa, M., Ohnishi, S., Ishibashi‐Ueda, H., Obata, H., Otani, K., Miyahara, Y., Tanaka, K., Shimizu, W., Nakazawa, K., Kangawa, K., et al. (2008) · Cell Transplantation · doi:10.3727/096368908787236594 · Cited by 42
“, number of humoral factors (6,7,9,12,13,19), and we have recently demonstrated that MSC conditioned me- for technical assistance.”
BackgroundGalli, D., Vitale, M., & Vaccarezza, M. (2014) · BioMed Research International · doi:10.1155/2014/762695 · Cited by 40
“, bFGF, HGF, IGF1, and VEGF), different groups have studied whether or not these molecules could mediate left ventricular functional improvement and reduction of infarct scar [66–69].”
BackgroundMesenchymal Stem Cells and Cardiovascular Disease: A Bench to Bedside Roadmap
Mazo, M. M., Araña, M., Pelacho, B., & Prósper, F. (2012) · Stem Cells International · doi:10.1155/2012/175979 · Cited by 41
Promigratory Activity of Oxytocin on Umbilical Cord Blood‐Derived Mesenchymal Stem Cells
Kim, Y. S., Kwon, J. S., Hong, M. H., Kim, J., Song, C. H., Jeong, M. H., Cho, J. G., Park, J.-C., Kang, J. C., & Ahn, Y. (2010) · Artificial Organs · doi:10.1111/j.1525-1594.2009.00894.x · Cited by 36
Safety and efficacy of bone marrow-derived autologous CD133 stem cell therapy
Das, H. (2010) · Frontiers in Bioscience-Elite · doi:10.2741/e265 · Cited by 36
“Postulated mechanisms for this process include paracrine effects, which may provide substrate for promoting myocardial healing and/or angiogenesis (17, 18).”
BackgroundEmerging roles of extracellular vesicles in cardiac repair and rejuvenation
Alibhai, F. J., Tobin, S. W., Yeganeh, A., Weisel, R. D., & Li, R. (2018) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00100.2018 · Cited by 39
“Our group has shown that MSCs derived from aged patients can be rejuvenated by seeding aged MSCs on a collagen scaffold containing immobilized VEGF and basic fibroblast growth factor (48) or by overexpressing neuron-derived neurotrophic factor (NDNF) (91).”
BackgroundInfluentialLiang, L., Wang, L., Zhou, S., Li, J., Li, M., Zhang, H., Cui, C., & Zhang, C. (2020) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-019-01687-4 · Cited by 38
Budgude, P., Kale, V. P., & Vaidya, A. (2020) · Cell Biology International · doi:10.1002/cbin.11313 · Cited by 38
“…evidence has proved that soluble paracrine factors secreted by MSCs such as cytokines, growth factors, and EVs were directly responsible for the observed therapeutic effects, as the conditioned medium (CM) from MSCs could mimic these salutary effects on damaged tissues (Gnecchi et al., 2005).”
Adult Stem Cell Therapy for Premature Ovarian Failure: From Bench to Bedside
Wang, M., Wang, Y., Li‐Ling, J., & Xie, H. (2021) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2020.0205 · Cited by 38
“129 Studies of POF have reached a similar conclusion.”
Lin, N., Tang, Z., Deng, M., Zhong, Y., Lin, J., Yang, X., Peng, X., & Xu, R. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.05.029 · Cited by 36
Wang, Y., Weil, B. R., Herrmann, J. L., Abarbanell, A. M., Tan, J., Markel, T. A., Kelly, M. L., & Meldrum, D. R. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00183.2009 · Cited by 37
Jiang, Y., Chen, L., Tang, Y., Ma, G., Shen, C., Qi, C., Zhu, Q., Yao, Y., & Liu, N. (2009) · Basic Research in Cardiology · doi:10.1007/s00395-009-0079-2 · Cited by 36
“cells [12, 33], cell protective cytokine secretions [10, 25], were suggested.”
BackgroundEmbryonic Stem Cells in Cardiac Repair and Regeneration
Singla, D. K. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2491 · Cited by 36
“Similarly, mesenchymal stem cells (MSCs) transfected with the Akt gene have better survival compared with that of wild-type MSC cells (9, 10).”
InfluentialStem Cell Factor Gene Transfer Improves Cardiac Function After Myocardial Infarction in Swine
Ishikawa, K., Fish, K. M., Agüero, J., Yaniz‐Galende, E., Jeong, D., Kho, C., Tilemann, L. M., Fish, L. A., Liang, L., Eltoukhy, A. A., et al. (2014) · Circulation Heart Failure · doi:10.1161/circheartfailure.114.001711 · Cited by 36
“It is now accepted that paracrine effects play a major role in the documented functional improvements after cell therapy in HF patients.(4,5) Preclinical investigations have identified several paracrine factors that contribute positively to cardiac repair after myocardial infarction (MI), such as vascular endothelial…”
BackgroundErythropoietin Responsive Cardiomyogenic Cells Contribute to Heart Repair Post Myocardial Infarction
Zafeiriou, M.-P., Noack, C., Unsöld, B. W., Didié, M., Pavlova, E., Fischer, H. J., Reichardt, H. M., Bergmann, M. W., El‐Armouche, A., Zimmermann, W., et al. (2014) · Stem Cells · doi:10.1002/stem.1741 · Cited by 35
Stem cells as screening tools in drug discovery
McNeish, J. D. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2007.06.005 · Cited by 37
Stem cell therapy for cardiac disease
Flynn, A. W., & O’Brien, T. (2011) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2011.543894 · Cited by 35
Sui, W., Hou, X., Che, W.-T., Chen, J., Ou, M., Xue, W., & Dai, Y. (2013) · Clinical Immunology · doi:10.1016/j.clim.2013.05.014 · Cited by 36
Prominent Vascularization Capacity of Mesenchymal Stem Cells in Collagen–Gold Nanocomposites
Hsieh, S., Chen, H.-J., Hsu, S., Yang, Y., Tang, C., Chu, M.-Y., Lin, P., Fu, R., Kung, M., Chen, Y., et al. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b09330 · Cited by 35
From biomimicry to bioelectronics: Smart materials for cardiac tissue engineering
Bolonduro, O. A., Duffy, B. M., Rao, A. A., Black, L. D., & Timko, B. P. (2020) · Nano Research · doi:10.1007/s12274-020-2682-3 · Cited by 36
“Regardless, many studies have shown functional benefits of injection or implantation of MSCs, indicating regenerative potential of the cells [42, 57, 58].”
BackgroundGao, S., Jin, Y., Ma, J., Wang, J., Wang, J., Shao, Z., Fan, T., Zhang, M., & Chang, D. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02919-8 · Cited by 37
Development of secretome-based strategies to improve cell culture protocols in tissue engineering
Cases-Perera, O., Blanco‐Elices, C., Chato‐Astrain, J., Miranda-Fernández, C., Campos, F., Crespo, P. V., Sánchez‐Montesinos, I., Alaminos, M., Martín‐Piedra, M. Á., & Garzón, I. J. (2022) · Scientific Reports · doi:10.1038/s41598-022-14115-y · Cited by 40
Lai, R. C., Tan, T. T., Sim, W. K., Zhang, B., & Lim, S. K. (2023) · Cytotherapy · doi:10.1016/j.jcyt.2023.03.015 · Cited by 35
Bone marrow derived stem cells in regenerative medicine as advanced therapy medicinal products.
Astori, G., Soncin, S., Cicero, V. L., Siclari, F., Sürder, D., Turchetto, L., Soldati, G., & Moccetti, T. (2010) · PubMed · Cited by 41
Byeon, Y.-E., Ryu, H.-H., Park, S. S., Koyama, Y., Kikuchi, M., Kim, W. H., Kang, K., & Kweon, O. (2010) · Cytotherapy · doi:10.3109/14653249.2010.481665 · Cited by 35
Recent Developments in Cardiovascular Stem Cells
Madonna, R., Ferdinándy, P., Caterina, R. D., Willerson, J. T., & Marian, A. J. (2014) · Circulation Research · doi:10.1161/circresaha.114.305567 · Cited by 37
Therapeutic Angiogenesis: Angiogenic Growth Factors for Ischemic Heart Disease
Henning, R. J. (2016) · Future Cardiology · doi:10.2217/fca-2016-0006 · Cited by 37
Hypoxia modulates cell migration and proliferation in placenta-derived mesenchymal stem cells
Li, L., Jaiswal, P. K., Makhoul, G., Jurakhan, R., Selvasandran, K., Ridwan, K., & Cecere, R. (2017) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2017.03.141 · Cited by 35
Xue, X., Liu, Y., Zhang, J., Liu, T., Yang, Z., & Wang, H. (2015) · Stem Cells International · doi:10.1155/2015/176409 · Cited by 34
“However, several evidences have showed that, instead of the transdifferentiation of MSCs into cardiomyocytes or endothelial cells, the paracrine of survival and angiogenic factors by MSCs played the main role in the cure of heart infarction by MSC transplantation [12, 16, 22].”
BackgroundHASF is a stem cell paracrine factor that activates PKC epsilon mediated cytoprotection
Huang, J., Guo, J., Beigi, F., Hodgkinson, C. P., Facundo, H. T., Zhang, Z., Espinoza‐Derout, J., Zhou, X., Pratt, R. E., Mirotsou, M., et al. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.11.010 · Cited by 37
“transcripts encoding for genes with a previously unassigned function [10, 11, 13].”
BackgroundSelf-citationHirata, M., & Yamaoka, T. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.10.032 · Cited by 37
Preparing the Bone Tissue Regeneration Ground by Exosomes: From Diagnosis to Therapy
Al-Sowayan, B. S., Alammari, F., & Alshareeda, A. T. (2020) · Molecules · doi:10.3390/molecules25184205 · Cited by 35
“Instead, it was hypothesized that the transplanted cells exert their tissue regenerative effect by releasing paracrine factors, which stimulate the tissue’s endogenous cells to recover [14,15].”
BackgroundBryk, M., Karnas, E., Mlost, J., Zuba‐Surma, E. K., & Starowicz, K. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15569 · Cited by 35
“…regeneration not only through their direct contribution to newly formed tissue due to the processes of proliferation and/or differentiation but also, or even predominantly, via their paracrine activity influencing cells residing in the site of injury (Gnecchi et al., 2005; Timmers et al., 2008).”
BackgroundZhang, P., Li, C., Liu, S., Zhang, M., Pi, W., Wang, B., Li, Q.-C., & Lu, C. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.335167 · Cited by 39
“Over the years, exosomes derived from mesenchymal stem cells have attracted increasing attention in relation to stem cell-regulated therapeutic processes because they play a vital role in intercellular communication and biological regulation (Gnecchi et al., 2005; Timmers et al., 2007; Phinney et al., 2015).”
BackgroundExtracellular vesicles: From bone development to regenerative orthopedics
Davies, O. G. (2023) · Molecular Therapy · doi:10.1016/j.ymthe.2023.02.021 · Cited by 36
Improving regenerating potential of the heart after myocardial infarction: Factor-based approach
Hwang, H., & Kloner, R. A. (2010) · Life Sciences · doi:10.1016/j.lfs.2010.01.004 · Cited by 34
Intramyocardial Navigation and Mapping for Stem Cell Delivery
Psaltis, P. J., Zannettino, A. C. W., Gronthos, S., & Worthley, S. G. (2009) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-009-9138-1 · Cited by 34
“Fertile areas of future research into cell-based therapy include the optimization of cell biology [ 27 ], the discovery of novel or second-generation cell types [4, 70], and the development of new delivery vectors [48] and strategies [36].”
BackgroundSpadaccio, C., Rainer, A., Trombetta, M., Centola, M., Lusini, M., Chello, M., Covino, E., Marco, F. D., Coccia, R., Toyoda, Y., et al. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01100.x · Cited by 34
“Additionally, new insights on cell-based myocardial repair have been recently reported, shifting emphasis on the importance of paracrine factors secreted by BM-derived cells [17–23].”
BackgroundChen, S., Ye, X., Yu, X., Xu, Q., Pan, K., Lu, S., & Yang, P. (2015) · PubMed · Cited by 42
Serum‐independent Cardiomyogenic Transdifferentiation in Human Endometrium‐derived Mesenchymal Cells
Ikegami, Y., Miyoshi, S., Nishiyama, N., Hida, N., Okamoto, K., Miyado, K., Segawa, K., Ogawa, S., & Umezawa, A. (2010) · Artificial Organs · doi:10.1111/j.1525-1594.2009.00859.x · Cited by 34
Advances in Cell-Based Therapy for Structural Heart Disease
Mazhari, R., & Hare, J. M. (2007) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2007.03.004 · Cited by 37
“Myoblasts secrete a variety of angiogeneic and antiapoptotic factors(21) similar to paracrine factors released from the bone marrow.(21-23) Avariety of clinical studies have assessed safety and efficacy of skeletal myoblasts using both intracoronary and intramyocardial modes of delivery in patients with acute myocardi…”
BackgroundStem cell transplantation for the treatment of myocardial infarction
Dai, W., Hale, S. L., & Kloner, R. A. (2005) · Transplant Immunology · doi:10.1016/j.trim.2005.09.004 · Cited by 34
Misao, Y., Takemura, G., Arai, M., Sato, S., SUZUKI, K., Miyata, S., Kosai, K., Minatoguchi, S., FUJIWARA, T., & Fujiwara, H. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.11.001 · Cited by 34
“Also, inhibition of apoptosis by a paracrine effect of BMT would be a possible mechanism for the beneficial effect, because the presence has been reported [25].”
BackgroundCombination of miRNA499 and miRNA133 Exerts a Synergic Effect on Cardiac Differentiation
Pisano, F., Altomare, C., Cervio, E., Barile, L., Rocchetti, M., Ciuffreda, M. C., Malpasso, G., Copes, F., Mura, M., Danieli, P., et al. (2014) · Stem Cells · doi:10.1002/stem.1928 · Cited by 33
Self-citationHuman mesenchymal stem cells and their paracrine factors for the treatment of brain tumors
Chan, J. K. Y., & Lam, P. Y. P. (2013) · Cancer Gene Therapy · doi:10.1038/cgt.2013.59 · Cited by 37
Richardson, J. D., Nelson, A. J., Zannettino, A. C. W., Gronthos, S., Worthley, S. G., & Psaltis, P. J. (2012) · Stem Cell Reviews and Reports · doi:10.1007/s12015-012-9366-7 · Cited by 36
“Insulin-like growth factor-1 also has pleiotropic activity, influencing cell growth, proliferation and survival predominantly by activating the Akt and mitogenactivated protein (MAP) kinase pathways.”
InfluentialCell Therapies in Cardiomyopathy: Current Status of Clinical Trials
Hao, M., Wang, R., & Wang, W. (2017) · Analytical Cellular Pathology · doi:10.1155/2017/9404057 · Cited by 37
Gupta, K., Ellison, D. D., Suhail, Y., Afzal, J. M., Woo, L. A., Kilic, O., Spees, J. L., & Levchenko, A. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1902598116 · Cited by 39
“This paradoxical finding has led to an increasing speculation that transient paracrine signaling is the principal mechanism accounting for BMSC function (1), explaining the survival and rescue of target tissues, including the heart (16, 18).”
BackgroundSabra, M., Karbasiafshar, C., Aboulgheit, A., Raj, S., Abid, M. R., & Sellke, F. W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073722 · Cited by 36
“The field of stem-cell-derived extracellular vesicles (EVs) advanced following findings that the therapeutic effects of cell-based therapies were mediated by paracrine actions [47,48].”
BackgroundLi, J.-K., Yang, C., Su, Y., Luo, J., Luo, M.-H., Huang, D.-L., Tu, G.-W., & Luo, Z. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.684496 · Cited by 36
“The beneficial effect of MSCs on renal tissue was related to the inhibition of renal tubular oxidative damage in a cisplatin-induced AKI model, manifested by the expression of nitrotyrosine and induction of Akt phosphorylation (59).”
BackgroundAdipose-derived stem cell secretome as a cell-free product for cutaneous wound healing
Ajit, A., & Gopalankutty, I. A. (2021) · 3 Biotech · doi:10.1007/s13205-021-02958-7 · Cited by 35
Mapping the Secretome of Dental Pulp Stem Cells Under Variable Microenvironmental Conditions
Bousnaki, M., Bakopoulou, A., Pich, A., Papachristou, E., Κritis, A., & Koidis, P. T. (2021) · Stem Cell Reviews and Reports · doi:10.1007/s12015-021-10255-2 · Cited by 38
“It has been found thatMSCs can affect the functions of macrophages through a paracrine action, hence influencing the immune responses and tissue repair processes following injury [76].”
BackgroundInfluentialIschemic preconditioning for cell-based therapy and tissue engineering
Hsiao, S. T.-F., Dilley, R. J., Dusting, G. J., & Lim, S. Y. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.12.002 · Cited by 36
RGDfK-Peptide Modified Alginate Scaffold for Cell Transplantation and Cardiac Neovascularization
Sondermeijer, H. P., Witkowski, P., Seki, T., van der Laarse, A., Itescu, S., & Hardy, M. A. (2017) · Tissue Engineering Part A · doi:10.1089/ten.tea.2017.0221 · Cited by 33
“The functional improvement of cardiac function upon treatment with a variety of bone marrow-derived precursor cells has generally been attributed to paracrine stimulation and stimulated neovascularization.(38) Surprisingly, this effect was not observed using scaffolds with the higher dose of 3 · 10(6) hMPCs.”
BackgroundFunctional multipotency of stem cells: Biological traits gleaned from neural progeny studies
Teng, Y. D. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.02.002 · Cited by 34
Guzman, M. J., Crisostomo, P. R., Wang, M., Markel, T. A., Wang, Y., & Meldrum, D. R. (2008) · Journal of Surgical Research · doi:10.1016/j.jss.2007.12.772 · Cited by 34
Current Status of Cell-Based Therapy for Heart Failure
Jakob, P., & Landmesser, U. (2013) · Current Heart Failure Reports · doi:10.1007/s11897-013-0134-z · Cited by 32
“In addition, MSCs release growth factors, indicating also a therapeutically important paracrine function and direct cell-cell interactions, which may additionally activate endogenous repair mechanisms.[75-79] Moreover, at least initially, MSCs prevent anti-donor T-cell responses and create an immunosuppressive milieu,…”
BackgroundMesenchymal stromal cells are present in the heart and promote growth of adult stem cells in vitro
Lushaj, E. B., Anstadt, E. J., Haworth, R. A., Roenneburg, D. A., Kim, J., Hematti, P., & Kohmoto, T. (2010) · Cytotherapy · doi:10.3109/14653249.2010.529890 · Cited by 32
Passipieri, J. A., Kasai-Brunswick, T. H., Suhett, G., Martins, A. B., Brasil, G. V., de Campos, D. B. P., Rocha, N. N., Ramos, I. P., Mello, D. B., Rodrigues, D. C., et al. (2014) · Stem Cell Research & Therapy · doi:10.1186/scrt490 · Cited by 32
“However, this capacity has been challenged, especially in the case of adult stem cells [33-37].”
BackgroundNew Delivery Systems of Stem Cells for Vascular Regeneration in Ischemia
Fakoya, A. O. J. (2017) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2017.00007 · Cited by 32
Extracellular vesicles and cardiovascular disease therapy
Amosse, J., Martínez, M. C., & Lay, S. L. (2017) · Stem Cell Investigation · doi:10.21037/sci.2017.11.07 · Cited by 33
Hoffman, T., Antovski, P., Tebon, P. J., Xu, C., Ashammakhi, N. A., Ahadian, S., Morsut, L., & Khademhosseini, A. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201909882 · Cited by 36
Stem cells therapy in acute myocardial infarction: a new era?
Carbone, R. G., Monselise, A., Bottino, G., Negrini, S., & Puppo, F. (2021) · Clinical and Experimental Medicine · doi:10.1007/s10238-021-00682-3 · Cited by 32
“Further mechanisms of repair induced by stem cells that have been demonstrated both in experimental models and humans are related to the self-regeneration properties and plasticity of cardiac tissue including: (1) direct cell differentiation from mononuclear cells to cardiac myocytes [2]; (2) cytokine-induced growth o…”
BackgroundNano-Medicine in the Cardiovascular System
Pretorius, D., Serpooshan, V., & Zhang, J. J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.640182 · Cited by 32
“ExosomeDelivery and “Synthetic”Exosome Design In the field of cardiovascular medicine, specifically the area related to treatment via implanted cells and structures, a lot of speculation remains regarding the extent of the effects that paracrine signaling has on the repair process (Gnecchi et al., 2005).”
BackgroundReversal of Cardiac Fibrosis and Related Dysfunction by Relaxin
Du, X., Xu, Q., Lekgabe, E. D., Gao, X., Kiriazis, H., Moore, X., Dart, A. M., Tregear, G. W., Bathgate, R. A. D., & Samuel, C. S. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2008.03780.x · Cited by 32
Chu, L., Hao, H., Luo, M., Huang, Y., Chen, Z., Lu, T., Zhao, X., Verfaillie, C. M., Zweier, J. L., & Liu, Z. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00948.x · Cited by 32
“Akt overexpression is reported to adequately maintain the pluripotency of mouse and monkey ESCs in undifferentiated phenotypes, reduces the apoptosis of mesenchymal stem cells, and enhances cardiac protection during cell therapy [37, 38].”
BackgroundCo-culture of mesenchymal stem cells with umbilical vein endothelial cells under hypoxic condition
Zhang, B., Yang, S., Zhang, Y., Sun, Z., Xu, W., & Ye, S. (2012) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-012-0031-9 · Cited by 33
Cardiac Cell Therapy: The Next (Re)Generation
Forte, E., Chimenti, I., Barile, L., Gaetani, R., Angelini, F., Ionta, V., Messina, E., & Giacomello, A. (2011) · Stem Cell Reviews and Reports · doi:10.1007/s12015-011-9252-8 · Cited by 35
“VEGF-A, FGF-2, IGF-1, and SDF-1 [28–30], with proangiogenic, anti-apoptotic and positive remodeling effects.”
HDAC Inhibition Elicits Myocardial Protective Effect through Modulation of MKK3/Akt-1
Zhao, T. C., Du, J., Zhuang, S., Liu, P. Y., & Zhang, L. X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065474 · Cited by 33
Self-citationLotfinia, M., Lak, S., Ghahhari, N. M., Johari, B., Maghsood, F., Parsania, S., Tabrizi, B. S., & Kadivar, M. (2016) · Iranian Biomedical Journal · doi:10.18869/acadpub.ibj.21.1.24 · Cited by 33
Angiogenic characteristics of human stromal vascular fraction in ischemic hindlimb
Jin, E., Chae, D., Son, M., & Kim, S. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.02.080 · Cited by 32
Yan, W., Li, D., Chen, T., Tian, G., Zhou, P., & Ju, X. (2017) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b16-00777 · Cited by 32
Yu, J. K., Franceschi, W. H., Huang, Q., Pashakhanloo, F., Boyle, P. M., & Trayanova, N. A. (2019) · Scientific Reports · doi:10.1038/s41598-019-45684-0 · Cited by 39
Adult mesenchymal stromal stem cells for therapeutic applications
Spitkovsky, D., & Hescheler, J. (2008) · Minimally Invasive Therapy & Allied Technologies · doi:10.1080/13645700801969758 · Cited by 41
“Additionally administration of conditioned medium from genetically modified MSC culture with exogenously introduced Akt-1 has a clear myocardium protective role in a model of myocardial infarction (127).”
BackgroundPrepare Cells to Repair the Heart: Mesenchymal Stem Cells for the Treatment of Heart Failure
Ohnishi, S., & Nagaya, N. (2007) · American Journal of Nephrology · doi:10.1159/000102000 · Cited by 38
“Interestingly, administration of conditioned medium obtained from MSC culture exerted cytoprotective effects on the myocardium in an animal model of myocardial infarction [”
BackgroundSilva, K. D., Kumar, P., & Choonara, Y. E. (2025) · Wound Repair and Regeneration · doi:10.1111/wrr.13251 · Cited by 34
“51 Another study performed by Ankersmit et al., 2009 indicated that tissue damage was inhibited in an acute myocardial infarction (AMI) rodent model after the infusion of stressed peripheral blood mononuclear cell (PBMC) suspensions.”
Bui, T. V. A., Hwang, J., Lee, J., Park, H., & Ban, K. (2021) · Korean Circulation Journal · doi:10.4070/kcj.2020.0518 · Cited by 31
Stem Cells in the Infarcted Heart
Singla, D. K. (2009) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-009-9151-4 · Cited by 31
“Next, CM from genetically modified Akt-MSC demonstrates several genes coding for VEGF, FGF-2, hepatocyte growth factor (HGF), IGF-1, and thymosin beta 4 were upregulated and might be potential mediators of antiapoptotic effects observed with CM [ 6 , 7]. Furthermore, the same group suggests that the major released pro…”
BackgroundBrunt, K. R., Wu, J., Chen, Z., Poeckel, D., Dercho, R. A., Melo, L. G., Funk, C. D., Ward, C. A., & Li, R. (2012) · Cell Transplantation · doi:10.3727/096368912x653002 · Cited by 33
Self-citationPagliari, S., Tirella, A., Ahluwalia, A. D., Duim, S. N., Goumans, M., Aoyagi, T., & Forte, G. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00210 · Cited by 33
“…mainly been ascribed to their ability to generate endothelial cells and exert pro-angiogenic and cardioprotective effects by paracrine mechanisms rather than to direct the generation of new contractile cells (Gnecchi et al., 2008; Meyer et al., 2009; Wöhrle et al., 2010; Loffredo et al., 2011).”
BackgroundLi, M., Yu, C., Cheng, L., Wang, M., Gu, X., Lee, K. K., Wang, T., Sung, Y. T. R., & Sanderson, J. E. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2006.068247 · Cited by 31
Stamp, L. A. (2017) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00018.2017 · Cited by 32
“Unlike some cell therapies, in which transient paracrine effects of transplanted cells is sufficient to induce long-term changes in disease states (27), it is almost certain that the long-term survival and integration of graft-derived enteric neurons will be essential for treating infants with Hirschsprung disease.”
BackgroundBreckwoldt, K., Weinberger, F., & Eschenhagen, T. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.11.010 · Cited by 36
Stem cell mobilisation for myocardial repair
Brunner, S., Engelmann, M. G., & Franz, W. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.8.11.1675 · Cited by 31
“The injection of modified BM-derived MSCs overexpressing Akt1 (Akt-MSC) has been shown to markedly limit the infarct size and reduce the apoptotic index of cardiomyocytes in rats after left coronary artery occlusion [98] .”
BackgroundZhang, S., Wang, S., Chen, J., Cui, Y., Lu, X., Xiong, S., Yue, C., & Yang, B. (2024) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2024.113775 · Cited by 30
Xu, R., Chen, X., Chen, J., Han, Y., & Han, B. (2008) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2008.05041.x · Cited by 32
“This early effect cannot be readily attributed to regeneration of the myocardium by transplanted cells.(11,12) Studies by Tang et al.”
BackgroundKearns‐Jonker, M., Dai, W., & Gunthart, M. (2012) · Journal of Stem Cell Research & Therapy · doi:10.4172/2157-7633.s1-005 · Cited by 30
Chen, H., Lee, Y., Sieber, M. A., Lu, H.-T., Wei, P., Wang, C., Peng, H., Chao, A., Cheng, P., Chang, S., et al. (2011) · Stem Cells and Development · doi:10.1089/scd.2011.0186 · Cited by 30
Stem cell–secreted factor therapy regenerates the ovarian niche and rescues follicles
Buigues, A., Marchante, M., de Miguel–Gómez, L., Martínez, J., Cervelló, I., Pellicer, A., & Herraiz, S. (2021) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2021.01.023 · Cited by 30
Hu, Z., Zhang, F., Yang, Z., Yang, N., Zhang, D., Zhang, J., & Cao, K. (2008) · Journal of Biomedical Science · doi:10.1007/s11373-008-9243-1 · Cited by 30
Use of Mesenchymal Stem Cells and Darbepoetin Improve Ischemia-Induced Acute Kidney Injury Outcomes
Altun, B., Yılmaz, R., Aki, F. T., Akoğlu, H., Zeybek, N. D., Pişkinpaşa, S., Uçkan, D., Puralı, N., Korkusuz, P., & Turgan, Ç. (2012) · American Journal of Nephrology · doi:10.1159/000339167 · Cited by 30
Dying blood mononuclear cell secretome exerts antimicrobial activity
Kasiri, M. M., Beer, L., Nemec, L., Грубер, Ф., Pietkiewicz, S., Haider, T. T., Simader, E., Traxler, D., Schweiger, T., Janik, S., et al. (2016) · European Journal of Clinical Investigation · doi:10.1111/eci.12667 · Cited by 30
Metadata
- Authors
- Gnecchi, M., He, H., Liang, O. D., Melo, L. G., Morello, F., Mu, H., Noiseux, N., Zhang, L., Pratt, R. E., Ingwall, J. S., & Dzau, V. J.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Dzau, Victor J
- ORCID
- Venue
- Nature Medicine
- Published
- 2005-04
- Volume
- 11
- Issue
- 4
- Pages
- 367-368
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2067591094
- Cited by
- 1,677
- References
- 7
- Citations by year
- 2026: 31 · 2025: 35 · 2024: 49 · 2023: 55 · 2022: 67 · 2021: 86 · 2020: 91 · 2019: 69 · 2018: 74 · 2017: 87 · 2016: 95 · 2015: 89 · 2014: 81 · 2013: 88 · 2012: 106
- FWCI
- 38.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Funders
- National Institutes of Health (1z01hl005320-01)
- National Heart, Lung, and Blood Institute (HL 73219, HL-58516, HL 72010, R01HL063985, HL 5320, R01HL058516, R01HL072010, HL-35610, R01HL073219, HL 63985)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Ischemia and Reperfusion
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Keywords
- paracrine signaling, mesenchymal stem cells, Akt signaling, myocardial ischemia, cardioprotection, cell therapy, exosomes, secretome
- MeSH terms
- Animals, Cells, Cultured, Myocardial Infarction, Myocardium, Proto-Oncogene Proteins, Cell Hypoxia, Bone Marrow Transplantation, Culture Media, Conditioned, Apoptosis, Protein Serine-Threonine Kinases, Intercellular Signaling Peptides and Proteins, Mesenchymal Stem Cell Transplantation, Green Fluorescent Proteins, Proto-Oncogene Proteins c-akt, Rats, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.